Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06778226 · ClinicalTrials.gov registry record
ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion
A clinical trial of Stroke, sponsored by University of Miami.
- Active
- Registry status
- 5,000
- Enrollment target
- 3
- Study locations
NCT06778226: Active study of Stroke, sponsored by University of Miami.
NCT06778226 is a study of Stroke that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 5,000 participants, below the 12,005-participant average among 454 other Stroke trials with a reported enrollment target (58% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06778226, a study of Stroke, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of TRIMIS is to study how a medical procedure by the name of endovascular therapy compares to medical treatment alone in patients with mild stroke and a blood vessel occlusion in the brain
Primary Outcome
Scores range from 0-6. (0 = normal, 6 = dead).
Conditions Studied
Study Locations (3)
Florida
- University of Miami - Miami
Massachusetts
- Boston Medical Center - Boston
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2026-05-01 |
What the registry record for NCT06778226 still lists
NCT06778226 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, below the 12,005-participant average among 454 other Stroke trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT06778226 reports a single indexed study location in Florida, Massachusetts, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06778226 about?
NCT06778226 is a clinical study titled "ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion". The purpose of TRIMIS is to study how a medical procedure by the name of endovascular therapy compares to medical treatment alone in patients with mild stroke and a blood vessel occlusion in the brain
What is the current status of trial NCT06778226?
This trial is currently active not recruiting. The enrollment target is 5,000 participants. The study started on 2018-01-01. Estimated completion is 2026-05-01.
What conditions does trial NCT06778226 study?
This clinical trial studies the following conditions: Stroke.
Who is sponsoring clinical trial NCT06778226?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06778226 being conducted?
This trial has 3 study locations across Florida, Massachusetts, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06778226's enrollment target sits among peer trials
5,000 15th of 454 higher than 439 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI